Pharmacovigilance Market by Clinical Trial Phases (Preclinical Animal Toxicity, Clinical Trial Phase I, II, III, Post Marketing Surveillance), By Method (Spontaneous Reporting, Intensified Adverse Drug Reaction Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring), By Service Providers (In-House, Contract Outsourcing), By End User (Hospitals, Pharmaceutical Companies), By Therapeutic Areas (Oncology, Cardiology, Respiratory Systems) - Growth, Forecast To 2025-2033
